Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) EPS (Basic) (2021 - 2026)

HeartSciences' EPS (Basic) history spans 6 years, with the latest figure at -$0.63 for Q1 2026.

  • For Q1 2026, EPS (Basic) rose 75.49% year-over-year to -$0.63; the TTM value through Jan 2026 reached -$4.94, up 32.97%, while the annual FY2025 figure was -$9.34, 50.16% up from the prior year.
  • EPS (Basic) reached -$0.63 in Q1 2026 per HSCS's latest filing, up from -$0.85 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.11 in Q2 2024 to a low of -$79.36 in Q2 2023.
  • Average EPS (Basic) over 5 years is -$7.38, with a median of -$1.58 recorded in 2025.
  • Peak YoY movement for EPS (Basic): plummeted 12909.84% in 2023, then soared 100.14% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$0.22 in 2022, then plummeted by 7136.36% to -$15.92 in 2023, then surged by 85.74% to -$2.27 in 2024, then surged by 62.56% to -$0.85 in 2025, then grew by 25.88% to -$0.63 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's EPS (Basic) are -$0.63 (Q1 2026), -$0.85 (Q4 2025), and -$1.58 (Q3 2025).